Norethindrone Acetate And Ethinyl Estradiol Tablet
Product Images NDC 0378-7280

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Norethindrone Acetate And Ethinyl Estradiol (NDC 0378-7280). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structures (36c49c83 7560 4ed4 Bdc5 F567a5633b94 01)

Chemical structure diagram showing the molecular structures of Ethinyl Estradiol and Norethindrone Acetate, the active ingredients in the drug product. The image displays chemical bonds and groups typical of steroidal hormones, labeled clearly with the compound names beneath each structure.*

FDA Label Image

Graph (36c49c83 7560 4ed4 Bdc5 F567a5633b94 02)

Bar chart depicting mortality rate (number of deaths per 100,000 woman users) by age group (15-24, 25-34, 35-44, 45+) comparing ever-users and controls for smokers and non-smokers. The chart shows increasing mortality rates with age, notably highest in ever-smoker users aged 45 and older.*

FDA Label Image

Blister With Instructions (36c49c83 7560 4ed4 Bdc5 F567a5633b94 03)

Medication blister pack for Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1 mg/0.02 mg, oral tablets. The pack contains 21 tablets arranged in three weeks of seven tablets each, labeled with the days of the week from Sunday to Saturday. Instructions indicate to start either as a Sunday starter or a Day-1 starter by placing a day label strip. The pack is labeled for Rx only and includes storage instructions at 20° to 25°C (68° to 77°F). The labeler is Mylan Pharmaceuticals Inc., with NDC 0378-7280.*

FDA Label Image

Day Sticker Label (36c49c83 7560 4ed4 Bdc5 F567a5633b94 04)

An instructional diagram showing six day label strips each containing the days of the week repeated in sequence. Below the strips, a text box explains how to start day 1 by selecting the strip that begins with the first day of the menstrual period and placing it over the blister days of the week for day tracking, with a note for Sunday period starts.*

FDA Label Image

Blister With Instructions (36c49c83 7560 4ed4 Bdc5 F567a5633b94 05)

A medication blister pack for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL Tablets USP, 1 mg/0.02 mg, containing 21 oral tablets. The pack is organized in three rows labeled Week 1, Week 2, and Week 3 with circles for each day of the week (Sunday to Saturday) for dosing guidance. The pack instructs users to start on Sunday or Day-1 starters and take pills left to right each week. It includes storage temperature instructions (20° to 25°C) and the labeler is Mylan Pharmaceuticals Inc.*

FDA Label Image

Day Sticker Label (36c49c83 7560 4ed4 Bdc5 F567a5633b94 06)

An instructional diagram showing a weekly calendar layout with days labeled Monday through Sunday repeatedly in rows. Below is a 'DAY 1 START' instruction box guiding users to pick a day label strip aligned to the first day of their menstrual period and place it over the area with preprinted days, starting with Sunday on the blister pack. It notes if the period starts on a Sunday, the step can be skipped.*

FDA Label Image

Image 01

Carton label for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL Tablets USP, oral tablets with strengths of 1 mg norethindrone acetate and 0.02 mg ethinyl estradiol. The label indicates the package contains 3 pouches, each with one blister pack of 21 tablets. Manufactured for Mylan Pharmaceuticals Inc., Morgantown, WV, made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.